- TWD5.63bn
- TWD6.38bn
- TWD16.57bn
- 30
- 53
- 54
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,905 | 7,502 | 7,652 | 6,723 | 16,566 |
Cost of Revenue | |||||
Gross Profit | 371 | 636 | 452 | 626 | 1,297 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,883 | 7,312 | 7,812 | 6,774 | 16,257 |
Operating Profit | 22.3 | 190 | -160 | -50.9 | 309 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.5 | 180 | -111 | 17.3 | 299 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.73 | 141 | -91.5 | 0.469 | 237 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.73 | 141 | -91.5 | 0.469 | 237 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 7.73 | 142 | -91.5 | 0.469 | 237 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.162 | 2.4 | -1.46 | 0.008 | 3.36 |
Dividends per Share | |||||
Special Dividends per Share |